FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Abramowitz Israel Maxx
 2. Date of Event Requiring Statement (Month/Day/Year)
09/14/2021		 3. Issuer Name and Ticker or Trading Symbol
Pasithea Therapeutics Corp. [KTTA]
(Last)
(First)
(Middle)
1111 LINCOLN ROAD, SUITE 500		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
Not a 10% owner
 5. If Amendment, Date Original Filed(Month/Day/Year)
09/14/2021
(Street)

MIAMI BEACH, FL 33139		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1,051,575
I
See Footnote (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Abramowitz Israel Maxx
1111 LINCOLN ROAD, SUITE 500
MIAMI BEACH, FL 33139		       Not a 10% owner

Signatures

/s/ Israel Maxx Abramowitz 10/07/2021
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This Form 3 was originally and incorrectly filed to disclose Israel Maxx Abramowitz as a 10% holder, specifically owning 1,051,575 shares of Common Stock through Epic Capital Inc. ("Epic"). At the time this Form 3 was originally filed, Mr. Abramowitz was the President and CEO of Epic and had sole voting and investment control with respect to the shares held by Epic. As such, Mr. Abramowitz may have be deemed to beneficially own the shares held directly by Epic. At this time, the 1,051,575 shares of Common Stock held by Epic represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Abramowitz is not a 10% holder.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.